Results 221 to 230 of about 982,599 (398)

Angiopoietins, Vascular Endothelial Growth Factors and Secretory Phospholipase A₂ in Ischemic and Non-Ischemic Heart Failure. [PDF]

J Clin Med, 2020
Varricchi G, Loffredo S, Bencivenga L, Ferrara AL, Gambino G, Ferrara N, de Paulis A, Marone G, Rengo G.   +8 more
europepmc   +1 more source

Prognostic significance of the expression of vascular endothelial growth factors A, B, C, and D and their receptors R1, R2, and R3 in patients with nonsmall cell lung cancer

Cancer, 2009
Enrique Carrillo de Santa Pau, F. Arias, E. Caso Peláez, Gemma María Muñoz Molina, Ignacio Sánchez Hernández, I. Muguruza Trueba, R. Moreno Balsalobre, Silvia Sacristán López, Alejandro Gómez Pinillos, María Del Val Toledo Lobo   +9 more
semanticscholar   +1 more source

Suppression of glioblastoma angiogenicity and tumorigenicity by inhibition of endogenous expression of vascular endothelial growth factor. [PDF]

, 1996
Shi‐Yuan Cheng, Hui Huang, Motoo Nagane, Xiang-Dong Ji, D Wang, Chao-Ming Shih, Wadih Arap, Chun-Ming Huang, Webster K. Cavenee   +8 more
openalex   +1 more source

TPMS‐Gyroid Scaffold‐Mediated Up‐Regulation of ITGB1 for Enhanced Cell Adhesion and Immune‐Modulatory Osteogenesis

Advanced Healthcare Materials, EarlyView.
A) SLM generates biomimetic bone scaffolds with consistent porosity but varying TPMS‐Gyroid unit cell designs (TG15, TG20, TG25, TG30). B) By enhancing the expression of ITGB1, TPMS‐Gyroid scaffolds can facilitate osteogenic differentiation in BMSCs and promote M2 polarization in macrophages.
Jing Wang, Zenan Huang, Zhenzhong Han, Jing Luan, Zihan Li, Xutong Guo, Dongxu Yang, Yazhou Cui, Jinxiang Han, Duo Xu   +9 more
wiley   +1 more source

Anti-Vascular Endothelial Growth Factors as a Potential Risk for Implant Failure: A Clinical Report. [PDF]

Case Rep Med, 2020
Emami E, de Grandmont P, Menassa M, Audy N, Durand R.   +4 more
europepmc   +1 more source

Expression and Functions of the Vascular Endothelial Growth Factors and Their Receptors in Human Basophils1

Journal of Immunology, 2006
A. de Paulis, N. Prevete, I. Fiorentino, F. Rossi, S. Staibano, N. Montuori, P. Ragno, Amelia Longobardi, Bianca Liccardo, A. Genovese, D. Ribatti, A. Walls, G. Marone   +12 more
semanticscholar   +1 more source

Patterns of brain angiogenesis after vascular endothelial growth factor administration in vitro and in vivo

, 1998
Jeffrey M. Rosenstein, Nina Mani, William F. Silverman, Janette M. Krum   +3 more
openalex   +1 more source

Heterodimers of Placenta Growth Factor/Vascular Endothelial Growth Factor [PDF]

, 1996
Yihai Cao, Hua Chen, Li Zhou, Ming‐Ko Chiang, Bela Anand‐Apte, James A. Weatherbee, Yongda Wang, Faye Fang, John G. Flanagan, Monica Lik-Shing Tsang   +9 more
openalex   +1 more source

Recent Applications of Mesoporous Silica Nanoparticles in Gene Therapy

Advanced Healthcare Materials, EarlyView.
The review summarizes the synthesis of mesoporous silica nanoparticles (MSNs) with modifiable surface properties, functionalization strategies, mechanism of therapeutic payload release, and current applications in gene therapy, focusing on their capabilities in the targeted delivery of therapeutic nucleic acids, CRISPR‐Cas systems, and other genetic ...
Tamanna Binte Huq, Punnya Anil Kumar Jeeja, Sudip Kumar Dam, Sabya Sachi Das, Juan L. Vivero‐Escoto   +4 more
wiley   +1 more source

Рівень в крові фактора росту ендотелію судин під час хіміопроменевої терапії хворих з нерезектабельними рецидивами раку прямої кишки

, 2003
Резюме. Встановлено, що застосування індометацину під час проведення хіміопроменевої терапії з приводу нерезектабельних рецидивів раку прямої кишки не тільки сприяє зниженню вмісту одного з основних факторів ангіогенезу — фактору росту ендотелію судин, а
Гуніна, Л.М., Коробко, В.Б., Кікоть, В.О., Лісняк, І.О., Сорокін, Б.В., Чорний, В.О.   +5 more
core